Observations of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial).

Abstract excerpt

The Quattro Trial compared the use of four HIV-1 reverse transcriptase (RT) inhibitors (zidovudine, lamivudine, loviride and zalcitabine), given either as four-drug combination therapy or monotherapy, with 8-week cycles of each drug, with zidovudine/lamivudine dual therapy. Observations of resistance associated and other mutations in the RT gene were made to determine whether therapy failure could be explained by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acetamides
• Share to Acquired Immunodeficiency Syndrome
• Share to Drug Therapy, Combination